+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Multiple Sclerosis"

From
From
From
From
Autoimmune Disease Diagnosis Market Report 2025 - Product Thumbnail Image

Autoimmune Disease Diagnosis Market Report 2025

  • Report
  • March 2025
  • 175 Pages
  • Global
From
Relapsing Remitting Multiple Sclerosis Market - Product Thumbnail Image

Relapsing Remitting Multiple Sclerosis Market

  • Report
  • January 2025
  • 250 Pages
  • Global
From
From
Multiple Sclerosis Market in US 2025-2029 - Product Thumbnail Image

Multiple Sclerosis Market in US 2025-2029

  • Report
  • December 2024
  • 139 Pages
  • United States
From
From
Multiple Sclerosis: Dynamic Market Forecast to 2026 - Product Thumbnail Image

Multiple Sclerosis: Dynamic Market Forecast to 2026

  • Report
  • November 2018
  • 53 Pages
  • Global
From
Multiple Sclerosis Forecast and Market Analysis to 2025 - Product Thumbnail Image

Multiple Sclerosis Forecast and Market Analysis to 2025

  • Report
  • July 2018
  • 765 Pages
  • Global
From
Loading Indicator

Multiple Sclerosis (MS) is a chronic, progressive neurological disorder that affects the central nervous system. It is classified as an autoimmune disorder, meaning that the body's immune system mistakenly attacks healthy tissue. MS is a major area of research within the field of Allergy and Immunology, as it is believed that the immune system plays a role in the development and progression of the disease. Treatment options for MS include medications, physical therapy, and lifestyle modifications. MS is a major health concern, with an estimated 2.3 million people living with the condition worldwide. Symptoms of MS can vary greatly from person to person, and can include fatigue, vision problems, muscle spasms, and difficulty with balance and coordination. Companies in the MS market include Biogen, Novartis, Sanofi, Merck, and Teva Pharmaceuticals. Show Less Read more